Trial Profile
A Randomized, Double-blind, Vehicle-controlled, Multi-center Study To Evaluate The Safety And Efficacy Of Topically Applied An2690 2.5%, 5.0%, And 7.5% Solutions Vs. Vehicle For The Treatment Of Adult Subjects With Onychomycosis Of The Great Toenail
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2018
Price :
$35
*
At a glance
- Drugs Tavaborole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Anacor Pharmaceuticals
- 20 May 2014 New trial record